Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Supply Chain

Business & Regulation Packaging

Desert, Tundra, and Archipelago: a Vaccine Epic

What did the industry learn about logistics during COVID vaccine rollout, and how will it make sure nobody gets left behind?

Manufacture Ingredients

Don't Get a Raw Deal

| Hunter Malanson

While you’re busy scaling up your bioprocesses, don’t forget about the secure supply of all critical raw materials

Business & Regulation Supply Chain

The Value of Dogged Determination

| Banks Bourne

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?

Business & Regulation Supply Chain

Building Resilience in the Supply Chain

| Sponsored by Thermo Fisher Scientific

We catch up with Christine Callahan from Thermo Fisher Scientific about how suppliers and customers need to reimagine their business models.

Business & Regulation Supply Chain

Strengthening Supply Chains Post-Pandemic

| Sponsored by Thermo Fisher Scientific

We spoke to Prateek Gadhoke, Global Head of Specialty Care Procurement at Sanofi, to ask what makes a strong supply chain.

Manufacture Advanced Medicine

Video Interview: Tamas Masztis

We interview Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company.

Manufacture Bioprocessing - Single Use Systems

Seeking Solutions in Biopharma

| Sponsored by Pall

Experts discuss how to tackle biopharma's need to move fast.

Manufacture Contract Manufacturing Services

Weathering the Storm Together - Part 1

| Stephanie Sutton

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

Manufacture Contract Manufacturing Services

Weathering the Storm Together - Part 2

| Stephanie Sutton

Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.

Manufacture Bioprocessing - Upstream & Downstream

Outsourcing Strategies to Expedite Viral-Vector Vaccine Development

| Sponsored by Sartorius

With the threat of COVID-19, vaccine developers needed to enter clinical development and scale-up at unprecedented speed.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register